While jaundice is a fairly common symptom of gallbladder cancer, persistent severe itchy skin, without known causes, too ...

Gallbladder cancer, a rare malignancy affecting the organ storing bile, often presents without early symptoms, leading to ...

Chemoradiation combined with immunotherapy significantly boosts survival in patients with resected extrahepatic ...

The 7 major gallbladder cancer markets size reached a value of US$ 51.6 Million in 2023. Looking forward, IMARC Group expects ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

FDA designates FF-10832 as an orphan drug for biliary tract cancer, promising enhanced treatment options for this aggressive ...

Olaparib demonstrated activity in a phase 2 trial of patients who had advanced biliary tract cancer with homologous recombination repair (HRR) mutations. Results from this trial were presented at the ...

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...